performance of surgery
laser refractive surgery sector
great volume of patients
reduced volume of patients
potential presence of keratoconus
KERASTOP
biomarkers
pathology
CORNEA PROJECT
company
theoretical risk of ectasia development
excimer laser technology
volume of candidates suitable
treatment of myopia
corneal surface
potential of leading
corneal transplantation
devastating disease
Ophthalmologists search
years of experience
clinical signs
situ diagnostic test
post-LASIK ectasia
current diagnostic tests
high levels of sensitivity
relevant experts
extreme conditions
problems
good outcome
area of biotechnology
human team
main business
private practice
eyes
initial stages
foundational partners
big jump
specificity
traumatic situation
doctors
risks
degradation of vision
ophthalmology
surgeries
safety
use
avoidance
positive EBITDA
euros
employments